Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,822 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,088 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01501604 | BKM120 in Cancers With PIK3CA Activating Mutations | withdrawn | Phase 2 | 0 | Massachusetts General HospitalOTHER | 0 | Sep 17, 2015 | clinicaltrials |
| NCT02263950 | A Phase 1/2a Study of LON002 in Subjects With Advanced Solid Tumours(LON002-002) | unknown | Phase 1 / Phase 2 | 87 | LondonPharma Ltd.INDUSTRY | 1 | Sep 7, 2015 | clinicaltrials |
| NCT00096941 | A Study to Evaluate Subjects Treated With rhuMab 2C4 (Pertuzumab) in a Previous Genentech Phase II Cancer Study | completed | Phase 2 | 3 | Genentech, Inc.INDUSTRY | 0 | Jun 11, 2015 | clinicaltrials |
| NCT01017731 | Study of Ramucirumab (IMC-1121B) Therapy and Corrected QT (QTc) Interval Changes | completed | Phase 2 | 68 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 10, 2015 | clinicaltrials |
| NCT02120118 | Combination of Hyperthermia and Concurrent Chemoradiotherapy (CCRT) in Treatment Failure Solid Tumors | withdrawn | Phase 2 | 0 | Shin Kong Wu Ho-Su Memorial HospitalOTHER | 1 | Jun 9, 2015 | clinicaltrials |
| NCT01764087 | A Study of KX2-391 With Paclitaxel in Patients With Solid Tumors | unknown | Phase 1 / Phase 2 | 60 | Hanmi Pharmaceutical Company LimitedINDUSTRY | 1 | May 18, 2015 | clinicaltrials |
| NCT00521144 | Obatoclax Mesylate and Topotecan Hydrochloride in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer or Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 22 | National Cancer Institute (NCI)NIH | 1 | May 5, 2015 | clinicaltrials |
| NCT00070252 | Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer | completed | Phase 1 / Phase 2 | 53 | National Cancer Institute (NCI)NIH | 1 | May 4, 2015 | clinicaltrials |
| NCT00278018 | Peritumoral Injection of Immature Dendritic Cells to Irradiated Skin Metastases of Solid Tumors | terminated | Phase 1 / Phase 2 | 20 | Hadassah Medical OrganizationOTHER | 1 | Apr 21, 2015 | clinicaltrials |
| NCT02339753 | Pharmacokinetic Study of Carboplatin in Pediatric Hematopoietic Stem Cell Transplantation | unknown | Phase 2 | 24 | The Korean Society of Pediatric Hematology OncologyNETWORK | 1 | Jan 16, 2015 | clinicaltrials |
| NCT01940601 | Pharmacodynamics, Pharmacokinetics, Efficacy and Safety of Balugrastim in Pediatric Patients With Solid Tumors | withdrawn | Phase 2 | 0 | Teva Branded Pharmaceutical Products R&D, Inc.INDUSTRY | 0 | Jan 14, 2015 | clinicaltrials |
| NCT00354523 | Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma | terminated | Phase 1 / Phase 2 | 21 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 17, 2014 | clinicaltrials |
| NCT01567163 | A Study of Ramucirumab and Docetaxel in Participants With Solid Tumors | completed | Phase 2 | 22 | Eli Lilly and CompanyINDUSTRY | 1 | Oct 16, 2014 | clinicaltrials |
| NCT01919866 | Safety Study of CD3/CD19 Depleted Haploidentical Stem Cells | unknown | Phase 1 / Phase 2 | 120 | University Children's Hospital TuebingenOTHER | 2 | Oct 8, 2014 | clinicaltrials |
| NCT02255292 | A Study: Pure CBD as Single-agent for Solid Tumor. | unknown | Phase 2 | 60 | Hadassah Medical OrganizationOTHER | 0 | Oct 2, 2014 | clinicaltrials |
| NCT00357500 | Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer | completed | Phase 2 | 101 | Dana-Farber Cancer InstituteOTHER | 1 | Oct 1, 2014 | clinicaltrials |
| NCT00910039 | Sunitinib Malate After Stereotactic Radiosurgery in Treating Patients With Newly Diagnosed Brain Metastases | terminated | Phase 2 | 14 | Case Comprehensive Cancer CenterOTHER | 1 | Sep 29, 2014 | clinicaltrials |
| NCT00429702 | Diphenhydramine, Lorazepam, and Dexamethasone in Treating Nausea and Vomiting Caused By Chemotherapy | terminated | Phase 2 | 7 | University of South FloridaOTHER | 2 | Jul 25, 2014 | clinicaltrials |
| NCT00002621 | Interferon Alfa in Treating Children With HIV-Related Cancer | completed | Phase 2 | 8 | Children's Oncology GroupNETWORK | 4 | Jul 24, 2014 | clinicaltrials |
| NCT01631279 | A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors | terminated | Phase 1 / Phase 2 | 33 | Proacta, IncorporatedINDUSTRY | 2 | Jun 16, 2014 | clinicaltrials |
| NCT00918281 | Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) Injection | completed | Phase 2 | 70 | GE HealthcareINDUSTRY | 1 | Jun 9, 2014 | clinicaltrials |
| NCT00706290 | Brief CBT for Anxiety and Advanced Cancer | completed | Phase 2 | 49 | Massachusetts General HospitalOTHER | 1 | Jun 6, 2014 | clinicaltrials |
| NCT00580034 | Allo Non-Myeloablative SCT Utilizing Mis-Matched Family Member Stem Cells Purged Using Campath | completed | Phase 2 | 176 | David Rizzieri, MDOTHER | 1 | Jun 3, 2014 | clinicaltrials |
| NCT01581060 | Phase I/II Dose-escalation Study to Investigate Safety and Pharmacokinetics/ Pharmacodynamics of WX-554 in Patients With Solid Tumours | terminated | Phase 1 / Phase 2 | 41 | Heidelberg Pharma AGINDUSTRY | 1 | May 16, 2014 | clinicaltrials |
| NCT00607880 | Study Comparing Two Types of Ports in Patients With Cancer Receiving Intravenous Chemotherapy | completed | Phase 2 | 100 | Mayo ClinicOTHER | 1 | May 9, 2014 | clinicaltrials |
| NCT00147225 | AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin | completed | Phase 1 / Phase 2 | 55 | M.D. Anderson Cancer CenterOTHER | 1 | May 8, 2014 | clinicaltrials |
| NCT00786838 | A Study to Assess the Potential Effects of a Single-Dose Administration of Trabectedin on the QT Intervals of the Electrocardiogram | completed | Phase 2 | 76 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 7 | Apr 11, 2014 | clinicaltrials |
| NCT00949117 | Cyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With Cancer | terminated | Phase 2 | 9 | University of South FloridaOTHER | 0 | Apr 2, 2014 | clinicaltrials |
| NCT00477607 | Alpha-Lipoic Acid in Preventing Hearing Loss in Cancer Patients Undergoing Treatment With Cisplatin | completed | Phase 2 / Phase 3 | 39 | US Department of Veterans AffairsFED | 1 | Mar 7, 2014 | clinicaltrials |
| NCT01058538 | A Dose Finding Pharmacokinetic Study of the Tumour-targeting Human L19IL2 Monoclonal Antibody-Cytokine Fusion Protein in Patients With Advanced Solid Tumours | completed | Phase 1 / Phase 2 | 33 | Philogen S.p.A.INDUSTRY | 2 | Feb 25, 2014 | clinicaltrials |
| NCT01131364 | Combination Therapy of F16IL2 and Doxorubicin in Solid Tumour Patients | terminated | Phase 1 / Phase 2 | 29 | Philogen S.p.A.INDUSTRY | 1 | Feb 25, 2014 | clinicaltrials |
| NCT01644097 | Probiotic Supplementation in Preventing Treatment-Related Diarrhea in Patients With Cancer Undergoing Chemotherapy | withdrawn | Phase 2 | 0 | Stanford UniversityOTHER | 1 | Feb 14, 2014 | clinicaltrials |
| NCT00066248 | Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment | completed | Phase 2 | 70 | University of South FloridaOTHER | 3 | Feb 3, 2014 | clinicaltrials |
| NCT00069927 | Adderall XR Compared With Concerta in Treating Young Cancer Patients With Memory, Attention, and Depression | terminated | Phase 2 | 12 | University of South FloridaOTHER | 1 | Feb 3, 2014 | clinicaltrials |
| NCT02045719 | Phase II Clinical Trial of Uncaria Tomentosa (Cat´s Claw) in Patients With Advanced Solid Tumors(cat´sclaw) | unknown | Phase 2 | 51 | Faculdade de Medicina do ABCOTHER | 1 | Jan 27, 2014 | clinicaltrials |
| NCT00084695 | Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases | unknown | Phase 2 | 25 | Milton S. Hershey Medical CenterOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00004979 | Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid Tumors | completed | Phase 1 / Phase 2 | — | Jonsson Comprehensive Cancer CenterOTHER | 0 | Jan 6, 2014 | clinicaltrials |
| NCT00894049 | A Study Comparing Non Myeloablative (Flu-TBI) and Reduced Intensity (FLU-BU-ATG) Conditioning in Allogenic Transplantation(ITAC02-01) | completed | Phase 2 | 148 | Institut Paoli-CalmettesOTHER | 1 | Jan 1, 2014 | clinicaltrials |
| NCT00697437 | Effect of Ketoconazole Inhibition of CYP3A on Urinary Excretion of Docetaxel | completed | Phase 2 | 10 | National University Hospital, SingaporeOTHER | 1 | Dec 10, 2013 | clinicaltrials |
| NCT00811655 | Stereotactic Radiosurgery in Treating Patients With Brain Metastases | terminated | Phase 2 | 6 | Duke UniversityOTHER | 1 | Nov 25, 2013 | clinicaltrials |
| NCT01337544 | Haploidentical Stem Cell Transplantation and IL-15 NK Cell Infusion for Paediatric Refractory Solid Tumours(NK) | terminated | Phase 1 / Phase 2 | 6 | Hospital Infantil Universitario Niño Jesús, Madrid, SpainOTHER | 1 | Nov 11, 2013 | clinicaltrials |
| NCT00002482 | Monoclonal Antibody Plus Cyclophosphamide in Treating Patients With Metastatic Cancer | unknown | Phase 1 / Phase 2 | — | St. Vincent Medical Center - Los AngelesOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00413283 | Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 63 | AmgenINDUSTRY | 8 | Oct 24, 2013 | clinicaltrials |
| NCT00020618 | Inhaled Morphine Compared With Morphine By Mouth in Treating Cancer Patients With Breakthrough Pain | completed | Phase 2 | — | Dana-Farber Cancer InstituteOTHER | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00003103 | Chemotherapy in Treating Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 57 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00003754 | Thalidomide and Cyclophosphamide in Treating Children With Recurrent or Refractory Childhood Cancers | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00842335 | A Phase 1/2, Open-Label, Dose-Escalation Study of JI-101, in Patients With Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 18 | Jubilant Innovation Ltd.INDUSTRY | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00003878 | Carmustine Implants in Treating Patients With Brain Metastases | completed | Phase 2 | — | New Approaches to Brain Tumor Therapy ConsortiumOTHER | 1 | Jun 21, 2013 | clinicaltrials |
| NCT00019331 | Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00021164 | Vaccine Therapy in Treating Patients With Metastatic Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2013 | clinicaltrials |
Data updated 22 days agoSource updated Sep 17, 2015source: clinicaltrials